Testing eye drops for blood flow in high eye pressure and glaucoma
Part of Eyes & vision clinical trials.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have high eye pressure (ocular hypertension) or are a glaucoma suspect.
- You have not used any eye drops or pills to lower eye pressure in the past 6 months.
- Your eye's drainage angle is open (checked by a doctor with a special lens).
- You have had a visual field test (to check side vision) within the last 6 months, and any vision loss is not severe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new combination eye drop (Rocklatan) to a standard one (Latanoprost) to see how well they control eye pressure over 24 hours. It may help people with open-angle glaucoma or high eye pressure find a more effective treatment.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
This trial tests a new eye drop combination (TFC-003) to lower eye pressure in people with primary open-angle glaucoma or ocular hypertension. It compares the new drug to existing treatments to see if it works better or is safer.
This study compares a special contact lens that measures eye pressure with standard eye-pressure testing. It may help people with glaucoma or ocular hypertension by improving how pressure is monitored.
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
Hear when a new Ocular Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.